MedAptus
Boston Millennia Partners, Portfolio Company, MedAptus®, Partners with athenahealth
01.13.15
MedAptus® announces that it has partnered with athenahealth through athenahealth’s More Disruption Please (MDP) program. Together the companies will work to link athenahealth’s growing network of more than 59,000 health care providers. Read Full Release
Collegium Pharmaceutical
Millennia Portfolio Company, Collegium Pharmaceutical, Completes Successful IPO
05.12.14
Millennia Portfolio Company, Collegium Pharmaceutical Inc., a specialty pharmaceutical company developing abuse-deterrent products, announced the closing of its initial public offering of 6,670,000 shares of its common stock at a price to the public of $12.00 per share. (Nasdaq:COLL) Read Full Release
Histogenics
Boston Millennia Portfolio Company, Histogenics, Completes Successful IPO
12.03.14
Millennia Portfolio Company, Histogenics, a regenerative medicine company, today announced the pricing of its underwritten initial public offering of 5,909,091 shares of its common stock at a price to the public of $11.00 per share. Read Full Release
CardioMEMS
Boston Millennia Partners Portfolio Company, CardioMEMS HF System Tests Positive
12.02.14
St. Jude Medical’s evaluation of the CardioMEMS Heart Failure (HF) System shows a significant reduction in 30-day hospital readmission rates for patients aged 65 and above. The System is a first-of-its-kind monitoring device that tracks the level of pressure borne by heart-failure patients. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, Announces Partnership with Entrada
10.22.14
MedAptus announces a partnership to integrate Entrada’s technology and services within the MedAptus Pro Charge Capture solution. Deploying Entrada’s dictation recording tools directly within its mobile application will enable MedAptus users to streamline documentation workflow. Read Full Release
CardioMEMS
Boston Millennia Partners Portfolio Company, CardioMEMS, Featured on CBS Evening News
09.22.14
A CBS News Boston special report features Millennia Portfolio Company, CardioMEMS', heart failure monitor in use at Brigham and Women's Hospital. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, Announces Kennedy University Hospitalists Adopt MedAptus for Inpatient Charge Capture Automation
09.24.14
Millennia Portfolio Company, MedAptus, announces that Kennedy University Hospitalists recently completed implementation of the company’s Professional (Pro) Charge Capture solution. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, Expands Physician Revenue Cycle Suite with Cloud-Based Provider Enrollment Solution
09.04.14
MedAptus® announces the launch of MedAptus Provider Enrollment, the company’s latest software component aimed at addressing the challenge of timely and complete physician credentialing. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Partners Portfolio Company, Odyssey Logistics & Technology Corp., Announces the Acquistion of ADS Logistics
08.26.14
Odyssey Logistics & Technology Corp., a leader in global supply chain logistics, announced the acquisition of Alternative Distribution Systems Logistics Company, Inc. (ADS Logistics), a full service metals logistics provider based out of Chesterton, Indiana. Read Full Release
PAREXEL International
PAREXEL International, Corp. Reports Fourth Quarter and Fiscal Year 2014 Results
08.08.14
PAREXEL International Corp. reports a 10.2% growth in consolidated service revenue to $510.6 million for Q42013 and an 11.8% growth in consolidated service revenue to $1.94 billion for the Fiscal Year 2014. Read Full Release
Collegium Pharmaceutical
Millennia Portfolio Company, Collegium Pharmaceutical, Announces Positive Top-Line Data from Phase III Study of Oxycodone DETERx®
08.06.14
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced positive top-line results from its pivotal Phase 3 study of the company’s investigational analgesic Oxycodone DETERx® that studied the treatment of patients with moderate-to-severe chronic low back pain. Read Full Release
MedAptus
Millennia Portfolio Company, MedAptus, Announces Children’s National Health System Deploys MedAptus’ ICD-10 Solution Acrossits Outpatient Enterprise
08.06.14
MedAptus® today announced that Children’s National Health System has completed deployment of the company’s Pro and Tech solutions across its numerous outpatient care locations. Read Full Release
Boston Millennia Partners
Dana Callow Featured on MassDevice
07.31.14
Managing Partner, Dana Callow, discusses the sale of portfolio company CardioMEMS to St. Jude Medical with MassDevice. Read Full Release
CardioMEMS
Boston Millennia Partners announces the sale of its portfolio company CardioMEMS to St. Jude Medical
06.03.14
Boston Millennia Partners is pleased to announce that St. Jude Medical (NYSE: STJ) has acquired the remaining 81 percent of CardioMEMS, Inc. it does not own for $375 million dollars. Read Full Release
Boston Millennia Partners
Boston Millennia Partners Congratulates PreCision Dermatology Management on $500 Million Sale to Valeant Pharmaceuticals International
07.07.14
With the receipt of Hart-Scott-Rodino clearance, the previously announced acquisition of Precision Dermatology by Valeant Pharmaceuticals International, Inc. for $500 million, closed July 7, 2014. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus, Announces First Coast Cardiovascular Institute Implemented Professional Charge Capture
06.10.14
First Coast Cardiovascular Institute (FCCI) has successfully implemented MedAptus’ Professional Charge Capture application and is experiencing significant improvement in efficiency. FCCI chose MedAptus based on functionality and strong track record of success in multi-specialty environment. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus, Enters into a Strategic Marketing Agreement with BESLER Consulting
04.24.14
MedAptus has entered into a strategic marketing agreement with BESLER Consulting, a leading provider of comprehensive revenue integrity services to healthcare organizations. Under the agreement, MedAptus and BESLER will promote each other’s healthcare services to their clients. Read Full Release
MedAptus
Boston Millennia Portfolio Company, Medaptus, Announces Methodist Healthcare Deploys MedAptus to Streamline Hospital-Based Charge Capture
03.26.14
Methodist Healthcare has implemented Medaptus’ Professional Charge Capture (Pro) solution to re-engineer paper-based processes for inpatient coding and billing. Methodist chose the MedAptus software based on ease-of-use, support for team care and robust real-time reconciliation capabilities. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, Announces Availability of Risk Severity Toolkit to Assist with HCC Coding
02.11.14
MedAptus® announces that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. Read Full Release
PAREXEL International
PAREXEL International Reports Second Quarter Fiscal Year 2014 Results
01.29.14
PAREXEL International Second Quarter Fiscal Year 2014 Results were announced and for the three months ended December 31, 2013 consolidated service revenue increased by 15.4% to $487.1 million. Read Full Release